Amiodarone versus implantable cardioverter defibrillator for asymptomatic nonsustained ventricular tachycardia in nonischemic dilated cardiomyopathy

DEFINITE showed a strong trend toward improved survival with an ICD.7 Although these results are encouraging, they do not definitively answer the question of whether patients with NIDCM derive significant survival benefit from an ICD. [...]recently, physicians have had to grapple with the uncertaint...

Full description

Saved in:
Bibliographic Details
Published in:The American heart journal 2004-05, Vol.147 (5), p.790-791
Main Authors: Cawley, Peter J, Al-Khatib, Sana M
Format: Article
Language:English
Subjects:
Amiodarone - therapeutic use
Anti-Arrhythmia Agents - therapeutic use
Biological and medical sciences
Cardiac arrhythmia
Cardiology. Vascular system
Cardiomyopathy, Dilated - complications
Defibrillators, Implantable
Drug therapy
Evidence-Based Medicine
Heart
Heart attacks
Humans
Medical sciences
Mortality
Myocarditis. Cardiomyopathies
Randomized Controlled Trials as Topic
Tachycardia, Ventricular - complications
Tachycardia, Ventricular - drug therapy
Tachycardia, Ventricular - therapy
Treatment Outcome
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:DEFINITE showed a strong trend toward improved survival with an ICD.7 Although these results are encouraging, they do not definitively answer the question of whether patients with NIDCM derive significant survival benefit from an ICD. [...]recently, physicians have had to grapple with the uncertainty surrounding the effect of ICD therapy on the survival of patients with NIDCM. Based on these results, the number of patients who could benefit from an ICD is substantial. [...]it is imperative that health care practitioners, academia, government, and industry team up to make this therapy affordable and widely available.
ISSN:0002-8703
1097-6744
DOI:10.1016/j.ahj.2004.02.002